WORLD
14:31, May 10, 2021
File photo
Covid jab maker BioNTech said Monday it would build a factory in Singapore that could produce hundreds of millions of doses of vaccines based on its mRNA technology per year in southeast Asia.
Construction of the manufacturing plant and a regional headquarters in Singapore will start this year, and the site could become operational by 2023, the German company said in a statement.
We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies
